BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 32764911)

  • 21. Detection of chronic obstructive pulmonary disease in primary care in Salzburg, Austria: findings from the real world.
    Weiss G; Steinacher I; Lamprecht B; Schirnhofer L; Kaiser B; Sönnichsen A; Studnicka M
    Respiration; 2014; 87(2):136-43. PubMed ID: 24296512
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of Prolonged Exacerbation Recovery in Chronic Obstructive Pulmonary Disease.
    Donaldson GC; Law M; Kowlessar B; Singh R; Brill SE; Allinson JP; Wedzicha JA
    Am J Respir Crit Care Med; 2015 Oct; 192(8):943-50. PubMed ID: 26151174
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of Asthma-COPD Overlap, Asthma, and Chronic Obstructive Pulmonary Disease Phenotypes in Patients with Airway Obstruction: Influence on Treatment Approach.
    Romem A; Rokach A; Bohadana A; Babai P; Arish N; Azulai H; Glazer M; Izbicki G
    Respiration; 2020; 99(1):35-42. PubMed ID: 31694032
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The COPD assessment test and St George's Respiratory Questionnaire: are they equivalent in subjects with COPD?
    Morishita-Katsu M; Nishimura K; Taniguchi H; Kimura T; Kondoh Y; Kataoka K; Ogawa T; Watanabe F; Arizono S; Nishiyama O; Nakayasu K; Imaizumi K; Hasegawa Y
    Int J Chron Obstruct Pulmon Dis; 2016; 11():1543-51. PubMed ID: 27462150
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A 1-year prospective cost-effectiveness analysis of roflumilast for the treatment of patients with severe chronic obstructive pulmonary disease.
    Rutten-van Mölken MP; van Nooten FE; Lindemann M; Caeser M; Calverley PM
    Pharmacoeconomics; 2007; 25(8):695-711. PubMed ID: 17640111
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The effect of one year outpatient pulmonary rehabilitation on patients with COPD].
    Zwick RH; Burghuber OC; Dovjak N; Hartl S; Kössler W; Lichtenschopf A; Müller R; Zwick H
    Wien Klin Wochenschr; 2009; 121(5-6):189-95. PubMed ID: 19412748
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Exacerbations and health care resource utilization in patients with airflow limitation diseases attending a primary care setting: the PUMA study.
    Montes de Oca M; Aguirre C; Lopez Varela MV; Laucho-Contreras ME; Casas A; Surmont F
    Int J Chron Obstruct Pulmon Dis; 2016; 11():3059-3067. PubMed ID: 27994446
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Correlation of the quality of life with the inspiratory capacity in patients with chronic obstructive pulmonary disease].
    Shen N; Yao WZ; Liu Z; Wang XH; Hao ZT; Liu XF
    Zhonghua Jie He He Hu Xi Za Zhi; 2010 Apr; 33(4):261-4. PubMed ID: 20646455
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Low-dose oral theophylline combined with inhaled corticosteroids for people with chronic obstructive pulmonary disease and high risk of exacerbations: a RCT.
    Devereux G; Cotton S; Fielding S; McMeekin N; Barnes PJ; Briggs A; Burns G; Chaudhuri R; Chrystyn H; Davies L; Soyza A; Gompertz S; Haughney J; Innes K; Kaniewska J; Lee A; Morice A; Norrie J; Sullivan A; Wilson A; Price D
    Health Technol Assess; 2019 Jul; 23(37):1-146. PubMed ID: 31343402
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Therapy with proton-pump inhibitors for gastroesophageal reflux disease does not reduce the risk for severe exacerbations in COPD.
    Baumeler L; Papakonstantinou E; Milenkovic B; Lacoma A; Louis R; Aerts JG; Welte T; Kostikas K; Blasi F; Boersma W; Torres A; Rohde GG; Boeck L; Rakic J; Scherr A; Tamm M; Stolz D
    Respirology; 2016 Jul; 21(5):883-90. PubMed ID: 26970108
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of comorbidities on COPD-specific health-related quality of life.
    Burgel PR; Escamilla R; Perez T; Carré P; Caillaud D; Chanez P; Pinet C; Jebrak G; Brinchault G; Court-Fortune I; Paillasseur JL; Roche N;
    Respir Med; 2013 Feb; 107(2):233-41. PubMed ID: 23098687
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Validation of the St George's respiratory questionnaire and risks factors affecting the quality of life of Lebanese COPD and asthma patients.
    Akiki Z; Hallit S; Layoun N; Cherfane M; Sacre H; Waked M; Salameh P
    J Asthma; 2019 Nov; 56(11):1212-1221. PubMed ID: 30359153
    [No Abstract]   [Full Text] [Related]  

  • 33. Exacerbations of Chronic Obstructive Pulmonary Disease and Quality of Life of Patients.
    Rubinsztajn R; Przybyłowski T; Maskey-Warzechowska M; Karwat K; Chazan R
    Adv Exp Med Biol; 2016; 884():69-74. PubMed ID: 26542597
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The cross-sectional and longitudinal association of the BODE index with quality of life in patients with chronic obstructive pulmonary disease.
    Lin YX; Xu WN; Liang LR; Pang BS; Nie XH; Zhang J; Wang H; Liu YX; Wang DQ; Xu ZY; Wang HW; Zhang HS; He ZY; Yang T; Wang C
    Chin Med J (Engl); 2009 Dec; 122(24):2939-44. PubMed ID: 20137478
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Assessing health-related quality of life in COPD: comparing generic and disease-specific instruments with focus on comorbidities.
    Wacker ME; Jörres RA; Karch A; Wilke S; Heinrich J; Karrasch S; Koch A; Schulz H; Watz H; Leidl R; Vogelmeier C; Holle R;
    BMC Pulm Med; 2016 May; 16(1):70. PubMed ID: 27160582
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Impact of chronic obstructive pulmonary disease on activities of daily living: results of the EIME multicenter study].
    Alvarez-Gutiérrez FJ; Miravitlles M; Calle M; Gobartt E; López F; Martín A;
    Arch Bronconeumol; 2007 Feb; 43(2):64-72. PubMed ID: 17288894
    [TBL] [Abstract][Full Text] [Related]  

  • 37. French-Canadian version of the Chronic Respiratory and St George's Respiratory questionnaires: an assessment of their psychometric properties in patients with chronic obstructive pulmonary disease.
    Bourbeau J; Maltais F; Rouleau M; Guímont C
    Can Respir J; 2004 Oct; 11(7):480-6. PubMed ID: 15505701
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Validation of the St. George's Respiratory Questionnaire in Nepal.
    Sherpa CT; LeClerq SL; Singh S; Naithani N; Pangeni R; Karki A; Chokhani RK; Han M; Gyetko M; Tielsch JM; Checkley W
    Chronic Obstr Pulm Dis; 2015 Sep; 2(4):281-289. PubMed ID: 28848850
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Referral and consultation in asthma and COPD: an exploration of pulmonologists' views.
    Schermer T; Smeenk F; van Weel C
    Neth J Med; 2003 Mar; 61(3):71-81. PubMed ID: 12765227
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Early response to inhaled bronchodilators and corticosteroids as a predictor of 12-month treatment responder status and COPD exacerbations.
    Calverley PM; Postma DS; Anzueto AR; Make BJ; Eriksson G; Peterson S; Jenkins CR
    Int J Chron Obstruct Pulmon Dis; 2016; 11():381-90. PubMed ID: 26952309
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.